ENTPD1 and colorectal carcinoma: The correlation between levels of ENTPD1/CD39 in the host and CRC progression has been confirmed in orthotopic transplanted murine cancer models; while in clinical samples, lower levels of ENTPD1/CD39 mRNA in malignant CRC tissues correlates with prolonged survival and less invasiveness (60).